SUBSCRIBE
SUBSCRIBE
News   Deals

Helicos BioSciences Corporation Sets IPO at 5.4 Million Shares, $13-$15

May 8, 2007 | 
1 min read
WASHINGTON, May 7 (Reuters) - Helicos BioSciences Corp., a genetic analysis technologies firm, set its planned initial public offering on Monday at 5.4 million shares at between $13 and $15 per share.

>>> Discuss This Story

IPO
MORE ON THIS TOPIC
Creative design. Desperate employee, office worker standing near question mark symbolizing business struggles, options. Choosing strategy for achieving goal. Concept of business, career development
Earnings
Tariffs Keep Biogen Execs Busy in Q1 but Impacts Expected To Be Minimal
May 1, 2025
 · 
3 min read
 · 
Annalee Armstrong
Paying double wages or giving double money, greed and lust, double work for double wages, one person splitting into two and claiming both
Deals
Novartis Strikes on M&A, Leading a Line of Big Pharmas With Cash to Spend
April 30, 2025
 · 
5 min read
 · 
Annalee Armstrong
New York City, New York United States - August 29 2021: NASDAQ, National Association of Securities Dealers Automated Quotations corporate logo sign near Times Square.
IPO
Swiss ADC Biotech Takes SPAC Track to NASDAQ
April 23, 2025
 · 
1 min read
 · 
Annalee Armstrong
Creative sketch collage of business people handshake gesture approval project development success colleagues cooperation support.
Deals
Genentech Offers up to $765M in Biobucks to Repertoire for I&I Drug Discovery
April 23, 2025
 · 
1 min read
 · 
Dan Samorodnitsky